SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after receiving a major analyst upgrade from Rothschild & Co that lifted its price target to $40, fueling community optimism about the company's best-in-class potential in the hidradenitis suppurativa market. Investors are actively discussing the upcoming 40-week long-term data readout at the AAD conference, with many betting that sustained positive clinical results will validate the firm's pipeline and reinvigorate long-standing buyout speculation.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing significant selling pressure as investors weigh robust long-term AI demand against mounting macro headwinds, including geopolitical tensions in the Middle East and a broader rotation out of high-valuation tech stocks. The community remains deeply divided, with many traders debating whether the current pullback offers a strategic entry point for long-term growth or signals a deeper correction amidst semiconductor supply chain risks and shifting market sentiment.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is surging as investors hedge against Middle Eastern geopolitical instability and the resulting threat to global energy supplies, particularly in the European natural gas sector. The stock has become a focal point for the trading community, which is actively discussing its low float, high cost-to-borrow fees, and the potential for a significant short squeeze.

Sysco Corp. engages in the selling, marketing, and distribution of food products to restaurants, healthcare and educational facilities, and lodging establishments. It operates through the following segments: U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other. The U.S. Foodservice Operations segment consists of U.S. Broadline operations, custom-cut meat and seafood companies, FreshPoint, and European Imports. The International Foodservice Operations segment includes operations outside of the United States which distribute a full line of food products and a wide variety of non-food products. The SYGMA segment represents U.S. customized distribution operations serving quick-service chain restaurant customer locations. The Other segment covers hotel supply operations. The company was founded by John F. Baugh in 1969 and is headquartered in Houston, TX.

Sysco Corp.

Sysco is trending as investors weigh strong operational performance and market leadership against ongoing macroeconomic headwinds and a tight labor market. The community is actively debating the company's defensive status, dividend reliability, and the potential impact of its strategic investments in supply chain technology and fleet electrification.

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Zymeworks BC Inc

Zymeworks Inc

Zymeworks is gaining significant attention after receiving FDA Fast Track Designation for its antibody-drug conjugate ZW191, a key development for treating advanced platinum-resistant ovarian cancer. The community is buzzing over this regulatory milestone, with active discussions focused on the drug's potential as a best-in-class therapy and the company's broader positioning as a high-potential candidate for M&A activity within the oncology sector.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Gold and Silver Corporation

Americas Gold and Silver is seeing significant community attention driven by a combination of surging silver and antimony prices, alongside the acquisition of the Crescent Mine. Investors are actively debating the stock's potential for a major re-rating as they monitor physical silver supply tightness, the companys internal operational growth, and the broader impact of critical mineral policies on domestic production.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets is trending as the community rallies around the recent launch of its token, with active discussions focused on the token's initial growth, upcoming supply burns, and the project's connections to established crypto entities. Investors are heavily debating the project's long-term utility, such as staking and exchange listings, while simultaneously calling for better chart visibility to track the asset's momentum.

Roma Green Finance Ltd. is a holding company, which engages in the provision of environmental, social and governance, sustainability, and climate change related advisory services through its subsidiaries. Its services include corporate and risk advisory, sustainability strategy services, climate risk advisory, ESG reporting services, and sustainable finance. The company was founded in 2018 and is headquartered in Hong Kong.

Roma Green Finance Ltd - Ordinary Shares - Class A

Roma Green Finance Ltd

Roma Green Finance is seeing increased attention as investors track its recent momentum, with the community actively debating whether the stock is primed for a breakout or remains a volatile candidate for a pump-and-dump. Traders are closely monitoring key support levels and volume patterns, frequently referencing its history of sharp price swings and the speculative potential often associated with small-cap stocks in this sector.

CRINGE is a Solana meme token centered around all images, videos, and actions which are cringe!  Warning: Cringe Alert! Remember, folks! Just like we don't judge people based on race, ethnicity, or color, we shouldn't judge them for being cringe. After all, cringe isn't ugly - it's just... special. 😉  Embrace your inner cringe, because in a world full of copycats, being cringey is the new cool!  Meme coins are driven by community, and our community is CRINGE as heck!

CRINGE

CRINGE is trending as community members speculate on its potential for high-percentage gains following a surge in volatility and discussions surrounding its low market capitalization. While some participants express enthusiasm for the asset's rapid price movements, others caution against the speculative nature of such micro-cap tokens, highlighting risks related to market manipulation and volatility.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending as investors monitor volatile price action and institutional interest, while ongoing community debates weigh the impact of geopolitical instability against long-term growth potential. Market sentiment remains split between those viewing recent dips as accumulation opportunities and others concerned about broader economic headwinds and regulatory hurdles.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tudor Investment Corp ET AL Makes New $2.03 Million Investment in Mirum Pharmaceuticals, Inc. $MIRM

Tudor Investment Corp ET AL acquired a new stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 27,654 shares of the compa...

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $125.00

TD Cowen upped their price objective on shares of Mirum Pharmaceuticals from $117.00 to $125.00 and gave the stock a "buy" rating in a research report on Friday...

Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?

Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Mirum Pharmaceuticals (NASDAQ:MIRM) Receives Buy Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $130.00 target price on shares of Mirum Pharmaceuticals in a research note on Monday...

Penn Capital Management Company LLC Sells 34,265 Shares of Mirum Pharmaceuticals, Inc. $MIRM

Penn Capital Management Company LLC lessened its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 10.0% during the 3rd quarter, according to its most recent filing with the...

Mirum Pharmaceuticals (NASDAQ:MIRM) SVP Jolanda Howe Sells 4,732 Shares

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) SVP Jolanda Howe sold 4,732 shares of the firm's stock in a transaction dated Monday, March 16th. The shares were sold at an average price...

Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Joanne Quan Sells 7,287 Shares

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) insider Joanne Quan sold 7,287 shares of the company's stock in a transaction dated Monday, March 16th. The shares were sold at an average...

Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Sells $670,258.26 in Stock

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) CFO Eric Bjerkholt sold 7,287 shares of the business's stock in a transaction that occurred on Monday, March 16th. The stock was sold at an...

Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) COO Sells 16,515 Shares of Stock

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) COO Peter Radovich sold 16,515 shares of the business's stock in a transaction on Monday, March 16th. The stock was sold at an average...

Mirum Pharmaceuticals (NASDAQ:MIRM) CEO Christopher Peetz Sells 40,985 Shares

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) CEO Christopher Peetz sold 40,985 shares of the business's stock in a transaction on Monday, March 16th. The stock was sold at an average...

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Mirum Pharmaceuticals Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.34	--	--	N/A
Q4 '25	$0.06	-$0.10	-280.15%	MISSED
Q3 '25	-$0.14	$0.05	135.67%	BEAT
Q2 '25	-$0.33	-$0.12	63.22%	BEAT
Q1 '25	-$0.33	-$0.30	9.05%	BEAT

MIRM
Mirum Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest MIRM News

MIRMMirum Pharmaceuticals Inc